Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases

FDA approves expanded use of CINtec PLUS Cytology

Learn how the SARS-CoV-2 Rapid Antigen Test works

 

 

 

Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2

Immunoassay for the quantitative determination of antibodies to the SARS-CoV-2 spike protein

Roche has been at the forefront in responding to global emerging pathogen threats, most recently with its efforts against the COVID-19 pandemic.

Sustainable tuberculosis diagnostics to reach our Targets

The world’s leading supplier of in vitro diagnostic solutions, instrument systems, tests, and services.

Enabling healthcare professionals to effectively diagnose and manage disease while personalizing patient treatment options

 

Providing staining and instrument systems that automate and optimize the tissue diagnostic process for faster, more standardized answers

 

 

 

 

 

 

 

 

 

 

 

Innovating next-generation sequencing solutions that enable a deeper understanding of genetic mutations and inherited diseases

 

 

 

 

 

 

 

 

 

Supporting experts in oncology research and practice with timely, confident decisions that help improve care for each cancer patient

 

 

 

 

 

 

 

Equipping diagnostics and pharmaceutical manufacturers with customized solutions for their ever-changing needs

Integrating diagnostics through physical and virtual workflow automation, software solutions, and business analytics

Dedicated to helping people with diabetes to live life as active and unrestricted as possible